A special focus on the vaccine industry.  

VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007.

We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.

Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up to receive news and benefits

Latest Research
Respiratory Syncytial Virus (RSV) mAbs forecast July '19 (New!)
Lyme Borreliosis vaccines forecast June '19 (New!)
A.baumannii vaccines forecast May '19 (New!)
Staphylococcus aureus BSI/SSI vaccines (USA) May '19 (New!)
Chikungunya vaccines forecast Mar '19
Respiratory Syncytial Virus (RSV) vaccines forecast Mar '19
mRNA vaccines - infectious diseases Jan '19
Lassa fever vaccines forecast Jan '19
MERS-CoV vaccines forecast Jan '19
Nipah virus vaccines forecast Jan '19
Seasonal influenza vaccines forecast Oct '18
ExPEC vaccines forecast Sept '18
Dengue vaccines (endemic) - with addendum Jun '18
HPV therapeutic vaccines forecast Apr '18
Shigella vaccines forecast Mar '18
Campylobacter vaccines forecast Mar '18
Dengue vaccines (travelers) Feb '18
Opioid use disorder vaccines forecast Feb '18
Pertussis booster vaccines Dec '17
CAR-T CLL commercial forecast Oct '17
CAR-T B-cell NHL commercial forecast Aug '17
Rhinovirus vaccines forecast May '17
CAR-T B-ALL commercial forecast May '17
HSV prophylatic vaccines Mar '17
CAR-T therapy overview Mar '17
HSV therapeutic vaccines Feb '17
Therapeutic cancer vaccines Feb '17
Japanese Encephalitis vaccines forecast Jan '17

Latest Articles
A new Lyme disease vaccine - bravery to be rewarded
Pfizer's BioNTech influenza deal - the bold latecomer
An opioid use disorder (OUD) vaccine
2016 FY results - the impact of 'real use' and true product innovation.
Vaccines in the Trump era
2016 - year of the flavivirus vaccine?
2017 places higher pressure on hospitals to avoid HAIs
A Zika vaccine - the case strengthens
The global influenza vaccine market - where next?
2015 FY - Pfizer grows vaccine industry.
A Zika vaccine - late to the party we must attend.
2015 Q2 - round up of results and R&D.
Human metapneumovirus - why the poor cousin of RSV?
Latest News
© 2019 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. We sponsor Group B Strep Support.